Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Department of Justice
Daiichi Sankyo
Healthtrust
Mallinckrodt
Deloitte

Generated: August 25, 2019

DrugPatentWatch Database Preview

Patent: 7,217,796

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,217,796
Title:Neutralizing human anti-IGFR antibody
Abstract: The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
Inventor(s): Wang; Yan (Scotch Plains, NJ), Greenberg; Robert (Sparta, NJ), Presta; Leonard (San Francisco, CA), Pachter; Jonathan A. (Maplewood, NJ), Hailey; Judith (Edison, NJ), Brams; Peter (Sacramento, CA), Williams; Denise (San Jose, CA), Srinivasan; Mohan (Cupertino, CA), Feingersh; Diane (Union City, CA)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:10/443,466
Patent Claims:see list of patent claims

Details for Patent 7,217,796

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2022-05-24 RX Orphan search
Eisai Inc ONTAK denileukin diftitox VIAL 103767 001 1999-02-05   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2022-05-24 RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2022-05-24 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Julphar
Accenture
Chubb
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.